Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsBone NeoplasmsGraft vs Host DiseaseTransplantation, AutologousBone and BonesWhole-Body IrradiationTransplantation ConditioningAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingOsteolysisHematopoietic Stem CellsCyclophosphamideHistocompatibilityTransplantation, IsogeneicBone Marrow DiseasesHematologic NeoplasmsCombined Modality TherapyKidney TransplantationRecurrenceHematopoiesisProstatic NeoplasmsMice, Inbred C57BLTreatment OutcomeLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveOsteoclastsRadiation ChimeraBone Marrow ExaminationTime FactorsImmunosuppressive AgentsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionBone ResorptionHepatic Veno-Occlusive DiseaseBone RemodelingRetrospective StudiesSurvival AnalysisBone Marrow NeoplasmsLymphoma, Non-HodgkinLeukemia, MyeloidTransplantation ImmunologyGraft vs Host ReactionImmunosuppressionStem Cell TransplantationLymphocyte DepletionAcute DiseaseLeukocyte TransfusionHeart TransplantationAntineoplastic Combined Chemotherapy ProtocolsT-LymphocytesOsteoblastsMyelodysplastic SyndromesSurvival RateFollow-Up StudiesSevere Combined ImmunodeficiencyColony-Forming Units AssayChimeraHLA AntigensHematologic DiseasesBreast NeoplasmsLung TransplantationCell Line, TumorActuarial AnalysisCyclosporineBone DensityLymphocyte TransfusionDisease-Free SurvivalPrognosisNeoplasm MetastasisLymphomaCell DifferentiationMice, SCIDNuclear FamilyCarmustineOrgan TransplantationMice, Inbred BALB CFlow CytometryGraft vs Tumor EffectPancytopeniaRANK LigandMice, NudeOsteoprotegerinLeukocyte CountAntineoplastic AgentsGraft vs Leukemia EffectCytarabineMultiple MyelomaEtoposide